Single-Use Fermenters for the Production of Biologics
Large-scale single-use fermentation technology using aerobic microbial expression systems offers an excellent complement to stainless steel bioreactors for clinical-to-commercial scale production of recombinant proteins and offers unique advantages for nucleic acid production.
Download this white paper to:
Learn about the benefits of single-use vs. stainless steel fermentation
Recognize appropriate use cases for single-use vs. stainless steel fermentation, based on therapeutic modality and manufacturing scalability
Understand what to look for in a CDMO supporting your microbial fermentation needs and more!
SEO plus – Test
20+ years at GSK, leading R&D activities on multiple vaccine programs
Recently held positions in industry include: Senior Director (Function Head), Protein Biochemistry; Director, Antigen Design & Prototype Production; and, Associate Director, Antigen Design and Protein Characterization.
Key areas of expertise are:
Process development of protein Biologics/Recombinant Antigens
Recombinant protein expression (mammalian, insect, yeast, bacterial)
Production/design of Viral Vectors, mRNA vaccines, Bacterial outer membrane vesicles
Protein Engineering and Structural Biology
Defining quality attributes, biophysical characterization of proteins, and analytical strategy
Post graduate degrees in Functional Genomics (Université Laval) and Bioinformatics (MIT); M. Sc. Microbiology and Immunology (Laval).